NEW YORK, May 03, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, LLC (the "Company" or "LifeSci"), the leading international investor relations and corporate communications firm dedicated to the life sciences sector, today announced the appointment of Tara Hartigan as a Director in the Company’s Corporate Access department. The addition of Mrs. Hartigan is representative of LifeSci’s continued commitment to providing the highest level of service to its clients by broadening access to the institutional investor community.
Based in New York, Mrs. Hartigan has over 17 years of capital markets experience. Prior to joining LifeSci, Mrs. Hartigan was a Managing Director at Jefferies LLC, focused on Research Sales and Corporate Access in the New York and Mid-Atlantic regions. She began her career at Adams, Harkness and Hill in Boston and remained with the firm through its merger with Canaccord Genuity in 2006. Mrs. Hartigan was a Managing Director at Canaccord Genuity until 2012, where she was responsible for Research Sales in the same regions. Mrs. Hartigan has significant experience marketing life sciences companies, as well as long-standing relationships with numerous institutional investors. Mrs. Hartigan is a graduate of the University of Rhode Island.
"We are pleased to have Tara join our team. She is a key addition to a global team of professionals with deep domain expertise in the life sciences and significant relationships within the investment community,” said Michael Rice, President and Co-Founder of LifeSci Advisors. "LifeSci has continuously enhanced its Corporate Access capabilities to better serve the needs of our clients. The firm now offers clients the opportunity to conduct institutional and high-net worth retail non-deal roadshows globally. ”
“I am pleased to be joining LifeSci’s platform at a particularly exciting time for the firm,” said Mrs. Hartigan. “LifeSci’s capabilities and its geographic reach are unique among healthcare-focused investor relations firms. I look forward to leveraging my industry expertise and deep relationships with institutional investors to provide a valuable service to the firm’s clients as a member of its Corporate Access team.”
Over the past several months, LifeSci has dramatically broadened its Corporate Access platform through investments in talent and resources. In addition to Mrs. Hartigan, the firm also recently added managing directors, Floriane Meyer (institutional corporate access in Switzerland and pan-European high-net worth retail), and Anne Chofflet (institutional corporate access in France and Germany). In the process, the firm’s Corporate Access platform has expanded globally, conducting non-deal roadshows in North America, Israel and throughout Western Europe.
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With a local presence in New York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of PhDs enables us to better understand our clients' R&D, regulatory, and commercial strategy, and our team of financial services, investor relations, and public relations specialists help our clients effectively communicate to the marketplace. This combination of life sciences, financial services, and investor relations competencies allows us to provide a valuable and unique service offering to our clients.
LifeSci Partners (www.lifescipartners.com) is the leading provider of comprehensive consulting services in the areas of investor relations, corporate communications, public relations and capital markets advisory. Combining deep domain expertise in the life sciences and decades of experience in capital markets and public relations, we deliver unparalleled services to life sciences companies globally. LifeSci Partners has a physical presence in New York, Chicago, London, Geneva and Israel.